Cyrus Harmon Olema Pharmaceuticals, Inc. (OLMA) insider trading activity

Cyrus Harmon is of Olema Pharmaceuticals, Inc.. Currently has a direct ownership of 764,140 shares of OLMA, which is worth approximately $4.7 Million. The most recent transaction as insider was on Dec 11, 2024, when has been sold 8,137 shares (Common Stock) at a price of $9.03 per share, resulting in proceeds of $73,477. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 764K

1.71% 3M change

17.5% 12M change

Total Value Held $4.7 Million

Cyrus Harmon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 11 2024	SELL Open market or private sale	$73,477 $9.03 p/Share	8,137 Reduced 1.05%	764,140 Common Stock
Dec 10 2024	SELL Open market or private sale	$77,358 $9.37 p/Share	8,256 Reduced 1.06%	772,277 Common Stock
Dec 09 2024	BUY Grant, award, or other acquisition	-	29,250 Added 3.61%	780,533 Common Stock
Jul 30 2024	SELL Open market or private sale	$14,523 $15.55 p/Share	934 Reduced 0.12%	751,283 Common Stock
Jul 29 2024	SELL Open market or private sale	$63,348 $15.58 p/Share	4,066 Reduced 0.54%	752,217 Common Stock
Jul 11 2024	SELL Open market or private sale	$61,300 $12.26 p/Share	5,000 Reduced 0.66%	756,283 Common Stock
Jun 28 2024	SELL Open market or private sale	$215,400 $10.77 p/Share	20,000 Reduced 2.56%	761,283 Common Stock
Jun 04 2024	SELL Open market or private sale	$61,650 $12.33 p/Share	5,000 Reduced 0.64%	781,283 Common Stock
Jun 03 2024	SELL Open market or private sale	$54,650 $10.93 p/Share	5,000 Reduced 0.63%	786,283 Common Stock
May 31 2024	SELL Open market or private sale	$141,150 $9.41 p/Share	15,000 Reduced 1.86%	791,283 Common Stock
May 06 2024	SELL Open market or private sale	$54,600 $10.92 p/Share	5,000 Reduced 0.62%	806,283 Common Stock
Apr 30 2024	SELL Open market or private sale	$142,650 $9.51 p/Share	15,000 Reduced 1.82%	811,283 Common Stock
Mar 28 2024	SELL Open market or private sale	$219,400 $10.97 p/Share	20,000 Reduced 2.36%	826,283 Common Stock
Feb 29 2024	SELL Open market or private sale	$317,750 $12.71 p/Share	25,000 Reduced 2.87%	846,283 Common Stock
Feb 01 2024	SELL Open market or private sale	$77,800 $15.56 p/Share	5,000 Reduced 0.57%	871,283 Common Stock
Jan 31 2024	SELL Open market or private sale	$305,750 $12.23 p/Share	25,000 Reduced 2.77%	876,283 Common Stock
Dec 29 2023	SELL Open market or private sale	$342,500 $13.7 p/Share	25,000 Reduced 2.7%	901,283 Common Stock
Nov 30 2023	SELL Open market or private sale	$314,250 $12.57 p/Share	25,000 Reduced 2.63%	926,283 Common Stock
Nov 22 2023	SELL Open market or private sale	$55,447 $13.9 p/Share	3,989 Reduced 0.42%	951,283 Common Stock
Nov 21 2023	SELL Open market or private sale	$62,293 $14.86 p/Share	4,192 Reduced 0.44%	955,272 Common Stock
Nov 20 2023	BUY Grant, award, or other acquisition	-	15,750 Added 1.62%	959,464 Common Stock
Nov 02 2023	SELL Open market or private sale	$78,200 $15.64 p/Share	5,000 Reduced 0.53%	943,714 Common Stock
Oct 31 2023	SELL Open market or private sale	$301,250 $12.05 p/Share	25,000 Reduced 2.57%	948,714 Common Stock
Sep 29 2023	SELL Open market or private sale	$310,250 $12.41 p/Share	25,000 Reduced 2.5%	973,714 Common Stock
Sep 05 2023	SELL Open market or private sale	$116,199 $11.62 p/Share	10,000 Reduced 0.99%	998,714 Common Stock

Cyrus Harmon

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OLMA shares.

Notify only if

Value

Insider Trading

Get notified when an Olema Pharmaceuticals, Inc. insider buys or sells OLMA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Olema Pharmaceuticals, Inc.

Track Activities on OLMA

Account